|
|
Automated Pharmacy Prior Authorization/Smart PA
 |
Smart PASM is the intelligent Prior Authorization decision support system. It uses a highly sophisticated clinical rules system to determine if evidence-based criteria for appropriate use are met. Smart PASM utilizes drug and medical claims data, as well as provider-supplied information when necessary. |
| Implementation Date |
Indiana Smart PASM Rule |
| January 1, 2012 |
Cox II and Brand NSAIDs |
| January 1, 2012 |
Aromatase Inhibitors |
| January 1, 2012 |
Brand Medically Necessary Anticonvulsants |
| January 1, 2012 |
Multiple Sclerosis Agents |
| April 1, 2011 |
Pulmonary Hypertensives |
| April 1, 2011 |
Welchol |
| January 1, 2011 |
Targeted Immunomodulators |
| January 1, 2011 |
Urinary Tract Antispasmodics |
| October 5, 2010 |
Duplicate Sedative Hypnotic/Benzodiazepine Therapy |
| June 1, 2010 |
Chantix |
| April 1, 2010 |
Effient |
March 16, 2010 |
Duplicate Stimulant Therapy |
March 9, 2010 |
Low Dose Atypical Anti-psychotic Therapy |
February 9, 2010 |
Duplicate Atypical Anti-psychotic Therapy |
February 9, 2010 |
Duplicate Typical Anti-psychotic Therapy |
| January 1, 2010 |
Marinol |
| January 1, 2010 |
Lidoderm |
| January 1, 2010 |
Xolair |
| January 1, 2010 |
Opiate Overutilization |
December 8, 2009 |
Duplicate SSRI and SNRI Anti-depressant Therapy |
November 1, 2009 |
15 Day Trial on New Atypical Anti-psychotic Therapy |
Please see bulletins bt200927 and bt200945 for additional details.
Archives
| |
